Commonwealth legislation

Therapeutic Goods (Listing) Notice 2009 (No. 6)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

What this does: This notice allows a specific type of algae called Chlorella vulgaris to be used as an active ingredient in listed medicines (over-the-counter complementary medicines like vitamins and herbal supplements).

Who it affects: Companies manufacturing or importing complementary medicines containing Chlorella vulgaris.

The rules: Products can only contain this ingredient if they are:

For oral use only (to be swallowed, not injected or applied to skin)
Low in iodine — the daily dose must contain less than 300 micrograms of iodine (this is a safety limit, as too much iodine can harm the thyroid)

Why it matters: This notice acts as a temporary approval. It lets these products be legally sold in Australia while waiting for permanent regulations to be updated. Once the regulations change to specifically include Chlorella vulgaris, this notice automatically stops having effect.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods (Listing) Notice 2009 (No. 6).

Therapeutic Goods (Listing) Notice 2009 (No. 6)

View image in the official source

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2009 (No. 6)

I, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the ARTG) for listed goods:

preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990 (the Regulations) that contain Chlorella vulgaris as a therapeutically active ingredient in listed medicines. subject to the following conditions:

- that such preparations are for oral use only; and

- the recommended daily dose must contain less than 300 micrograms of iodine.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the ARTG for listed goods.

Dated this 8th day of October 2009

(signed by)

Dr Rohan Hammett

Delegate of the Minister for Health and Ageing

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Therapeutic Goods (Listing) Notice 2009 (No. 6)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2009 (No. 6)

preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990 (the Regulations) that contain Chlorella vulgaris as a therapeutically active ingredient in listed medicines. subject to the following conditions:

- that such preparations are for oral use only; and

- the recommended daily dose must contain less than 300 micrograms of iodine.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Dated this 8th day of October 2009

(signed by)

Dr Rohan Hammett

Delegate of the Minister for Health and Ageing